Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/81751
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils

AutorLorrio, Silvia; Sobrado, Mónica CSIC; Roda, José M.; López, Manuela G.
Fecha de publicación2007
EditorAmerican Society for Pharmacology and Experimental Therapeutics
CitaciónJournal of Pharmacology and Experimental Therapeutics 322(2): 591-599 (2007)
ResumenGalantamine, currently used in Alzheimer's patients, has shown neuroprotection in hippocampal slices subjected to oxygen-glucose deprivation. Here, we present an in vivo study to evaluate the potential neuroprotective effects of galantamine in a transient global cerebral ischemia model in gerbils. Three treatment protocols were used. In the pretreatment protocol, gerbils were treated before ischemia and for 3 consecutive days thereafter. Eight groups of animals were included: sham operation plus placebo, 10 mg/kg mecamylamine and 10 mg/kg galantamine, respectively; and ischemia plus placebo, 10 mg/kg mecamylamine, 1 mg/kg galantamine, and 10 mg/kg galantamine and 10 mg/kg mecamylamine plus galantamine, respectively. Postischemia protocols included three groups of animals: sham operation, ischemia plus placebo, and ischemia plus 10 mg/kg galantamine; substances were administered 3 or 6 h after ischemia and for 2 consecutive days thereafter. Pyramidal neurons surviving in the cornus ammonis 1 region of the hippocampus were evaluated 72 h after reperfusion, terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) histochemistry, caspase-3 and superoxide dismutase (SOD)-2 immunohistochemistries, and Western blottings were performed, and object placement tests were carried out. Galantamine significantly increased the number of living pyramidal neurons after ischemia-reperfusion injury. Galantamine significantly reduced TUNEL, active caspase-3, and SOD-2 immunoreactivity. The nicotinic antagonist mecamylamine blocked the protective effects of galantamine. The neuroprotective effects of galantamine were preserved even when first administered at 3 h postischemia. These results correlated with the performance in the object placement test. This study shows that galantamine provides in vivo neuroprotection and memory recovery against global cerebral ischemia, even when administration begins 3 h postischemia. Copyright © 2007 by The American Society for Pharmacology and Experimental Therapeutics.
URIhttp://hdl.handle.net/10261/81751
DOI10.1124/jpet.107.122747
Identificadoresdoi: 10.1124/jpet.107.122747
issn: 0022-3565
e-issn: 1521-0103
Aparece en las colecciones: (IIBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

54
checked on 21-mar-2024

WEB OF SCIENCETM
Citations

47
checked on 23-feb-2024

Page view(s)

334
checked on 27-mar-2024

Download(s)

98
checked on 27-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.